Pramlintide as an adjunct to insulin therapy improved glycemic and weight control in people with type 1 diabetes during treatment for 52 weeks

被引：0

|

作者：

Gottlieb, A

Velte, M

Fineman, M

Kolterman, O

机构：

来源：

DIABETES | 2000年 / 49卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

439

引用

收藏

页码：A109 / A109

页数：1

相关论文

共 50 条

[1] Pramlintide as an adjunct to insulin therapy improved glycemic and weight control in people with type 2 diabetes during treatment for 52 weeks
Fineman, M
Gottlieb, A
Skare, S
Kolterman, O
[J]. DIABETES, 2000, 49 : A106 - A106
[2] Pramlintide treatment for 52 weeks improved glycemic and weight control in people with type 1 diabetes
Gottlieb, A
Velte, M
Fineman, M
Kolterman, O
[J]. DIABETOLOGIA, 2000, 43 : A47 - A47
[3] 52 weeks pramlintide therapy as an adjunct to insulin improved metabolic control in people with type 2 diabetes
Fineman, M
Gottlieb, A
Skare, S
Kolterman, O
[J]. DIABETOLOGIA, 2000, 43 : A204 - A204
[4] Pramlintide (human amylin analogue) as an adjunct to insulin therapy in patients with type 1 diabetes improved glycemic control over 2 years
Kolterman, OG
Bahner, A
Gottlieb, A
Fineman, M
[J]. DIABETES, 1999, 48 : A104 - A105
[5] Amylin replacement with pramlintide as an adjunct to insulin therapy facilitates a combined improvement in glycemic and weight control in type 2 diabetes.
Maggs, DG
Weyer, C
Burrell, T
Gottlieb, AD
Shen, LZ
Kolterman, OG
[J]. DIABETOLOGIA, 2001, 44 : A237 - A237
[6] Amylin replacement with pramlintide as an adjunct to insulin therapy facilitates a combined improvement in glycemic and weight control in type 2 diabetes.
Maggs, DG
Weyer, C
Burrell, T
Gottlieb, AD
Shen, LZ
Kolterman, OG
[J]. DIABETOLOGIA, 2001, 44 : A237 - A237
[7] Pramlintide as adjunctive treatment to insulin in type 2 diabetes resulted in improved glycemic control and concomitant weight loss
Maggs, DG
Burrell, TA
Fineman, MS
Kolterman, OG
[J]. DIABETES, 2001, 50 : A124 - A125
[8] Effects of six months administration of pramlintide as an adjunct to insulin therapy on metabolic control in people with type 1 diabetes
Fineman, M
Bahner, A
Gottlieb, A
Kolterman, OG
[J]. DIABETES, 1999, 48 : A113 - A114
[9] Addition of pramlintide to insulin therapy in type 1 diabetes: Impact on glycemic end weight control stratified by BMI
Fineman, M
Maggs, D
Burrell, T
Velte, M
Kolterman, O
[J]. DIABETES, 2001, 50 : A112 - A112
[10] Pramlintide improved glycemic control and reduced weight in patients with type 2 diabetes using basal insulin
Riddle, Matthew
Frias, Juan
Zhang, Bei
Maier, Holly
Brown, Carl
Lutz, Karen
Kolterman, Orville
[J]. DIABETES CARE, 2007, 30 (11) : 2794 - 2799

← 1 2 3 4 5 →